Global Pharmaceuticals & Biotech Breakout Stocks

argenx

Market Cap: €56.4b

A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.

Moderna

Market Cap: US$57.9b

A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.

BioNTech

Market Cap: US$29.3b

Engages in the development and commercialization of immunotherapies in Germany.

Genscript Biotech

Market Cap: HK$75.3b

An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.

Twist Bioscience

Market Cap: US$9.1b

Manufactures and sells synthetic DNA-based products.

Amylyx Pharmaceuticals

Market Cap: US$4.3b

A clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States.

Walvax Biotechnology

Market Cap: CN¥25.7b

Engages in the research and development, manufacture, and distribution of vaccines in China and internationally.

SELLAS Life Sciences Group

Market Cap: US$3.1b

A late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States.

Maravai LifeSciences Holdings

Market Cap: US$2.2b

A life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America.

Personalis

Market Cap: US$2.0b

Develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally.

Basilea Pharmaceutica

Market Cap: CHF 801.2m

A Swiss commercial-stage biotech company focused on developing and commercializing treatments for severe bacterial and fungal infections.

Immix Biopharma

Market Cap: US$977.2m

A clinical-stage biopharmaceutical company, engages in the development of chimeric antigen receptor cell therapy in light chain Amyloidosis and immune-mediated diseases in the United States and Australia.

Jenkem Technology

Market Cap: CN¥6.5b

Engages in the research, development, production, and sale of medical and pharmaceutical polyethylene glycol (PEG), and its derivatives in China and internationally.

4D Molecular Therapeutics

Market Cap: US$874.5m

A late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and the United States.

Nuvectis Pharma

Market Cap: US$767.6m

A clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology.

Hunan Hansen Pharmaceutical

Market Cap: CN¥5.1b

Engages in the production and sale of traditional Chinese preparations in China and internationally.

Shanghai Shenqi Pharmaceutical Investment Management

Market Cap: CN¥4.5b

Operates as a pharmaceutical manufacturing holding investment company in China.

Contineum Therapeutics

Market Cap: US$646.7m

A clinical stage biopharmaceutical company, engages in developing of small molecules different therapies for neuroscience, inflammation, and immunology indications in the United States.

OmniAb

Market Cap: US$629.5m

A biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada.

Xinjiang Tianshan Animal Husbandry Bio-engineering

Market Cap: CN¥3.1b

Xinjiang Tianshan Animal Husbandry Bio-engineering Co., Ltd.

ProQR Therapeutics

Market Cap: US$330.2m

A clinical-stage biotechnology company, focuses on the discovery and development of novel therapeutic medicines.

AVITA Medical

Market Cap: US$311.1m

Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.

Nykode Therapeutics

Market Cap: NOK 1.5b

A clinical-stage biopharmaceutical company, discovers and develops novel immunotherapies for the treatment of cancer and autoimmune diseases.

Cypherpunk Technologies

Market Cap: US$153.0m

A privacy technology company, implements a digital asset strategy anchored by Zcash in the United States.

Psomagen

Market Cap: ₩78.0b

Engages in the provision omics solutions and contract laboratory services.

More Life

Market Cap: CA$34.3m

A biotech company, focuses on advancing solutions to optimize human, animal, and plant health in Canada.

Bilcare

Market Cap: ₹2.3b

Provides pharmaceutical packaging research solutions in India and internationally.

Pharmala Biotech Holdings

Market Cap: CA$28.9m

A biotechnology company, engages in the development, manufacture, and sale of MDMA and MDXX class molecules in service to the burgeoning clinical research community.

BioVie

Market Cap: US$14.7m

A clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States.

Aton

Market Cap: €12.6m

Operates as a bioscience company in France.

Malaysian Genomics Resource Centre Berhad

Market Cap: RM 57.4m

Provides genetics, genomics, immunotherapy, and biopharmaceutical services in Malaysia.

International Stem Cell

Market Cap: US$4.0m

A clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally.

Emmaus Life Sciences

Market Cap: US$2.3m

A commercial-stage biopharmaceutical company, discovers, develops, markets, and sells treatments and therapies primarily for rare and orphan diseases in the United States and internationally.

ObsEva

Market Cap: US$11.7k

A biopharmaceutical company, focuses on the development of novel therapies to improve women’s reproductive health.